The uPAR-targeted group showed stable inhibition of tumor growth (Fig. 8c–d), with negligible systemic toxicity (Fig. 8e) and reduced lung metastasis (Fig. 8f–g) [188]. The gene discussed is PLAUR; the disease is neoplasm.